Mergers & Acquisitions


Current filters:


Popular Filters

751 to 775 of 915 results

Shire inks deal to buy Pervasis, adding Ph II drug candidate


Ireland-headquartered biopharma firm Shire (LSE: SHP) said yesterday that it has signed an agreement…

Mergers & AcquisitionsPervasis TherapeuticsPharmaceuticalShire

Valeant Pharma to acquire podiatry firm Pedinol


In a fourth takeover deal so far this year, Canadian drugmaker Valeant Pharmaceuticals International.…

Mergers & AcquisitionsPedinol PharmacalPharmaceuticalValeant Pharmaceuticals

Takeda to acquire URL Pharma for $800 million


Japanese drug major Takeda Pharmaceutical (TYO: 4502) said yesterday that it has reached agreement to…

ColcrysMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsUloricURL Pharma

Arrowhead takes over Alvos Thera in stock deal


USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) says it has acquired Alvos Therapeutics…

Alvos TherapeuticsArrowhead ResearchBiotechnologyMergers & AcquisitionsPharmaceutical

Amgen to snap up KAI Pharma for $315 million


In a second acquisition announced so far this year, global biotech leader Amgen (Nasdaq: AMGN) said yesterday…

AmgenBiotechnologyKAI PharmaceuticalsMergers & AcquisitionsNephrology and Hepatology

Newron licenses safinamide to Zambon for EU and USA


Italian drug developer Newron Pharmaceuticals (SIX: NWRN) says that it has signed a strategic collaboration…

LicensingMergers & AcquisitionsNeurologicalNewron PharmaPharmaceuticalsafinamideZambon

IBA to set up new radiopharma company with SK Capital


Belgium-based Ion Beam Applications (IBA.) and SK Capital Partners, a US private investment firm, have…

IBA MolecularMergers & AcquisitionsPharmaceutical

Investor Icahn slams Amylin for not revealing B-MS bid


Billionaire US investor Carl Icahn has sent a blistering open letter to the board of US biotech company…

AmylinBiotechnologyBristol-Myers SquibbMergers & AcquisitionsPharmaceutical

Roche presses on with takeover, despite further rejection by Illumina board


Swiss drug major Roche (ROG: SIX), admitting disappointment that the board of Illumina (Nasdaq: ILMN)…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

GlaxoSmithKline ups stake in COPD drug partner Theravance


UK pharma giant GlaxoSmithKline (LSE: GSK) has increased its equity stake in USA-based Theravance (Nasdaq:…

GlaxoSmithKlineMergers & AcquisitionsPharmaceuticalTheravance

Government, academic and venture firms come together in March to fund translational and early-stage development


A host of new initiatives focused on funding translational research and early-stage companies brought…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Valeant to buy Russian OTC drugmaker


In its third takeover announcement this year, Canadian drugmaker Valeant Pharmaceuticals International…

Mergers & AcquisitionsNatur ProduktPharmaceuticalValeant Pharmaceuticals

Islet Sciences closes stock acquisition of diabetes drug developer DiaKine


New York. USA-based biotech company Islet Sciences (OTC.BB: ISLT),said Friday that it has closed its…

BiotechnologyDiabetesDiaKine TherapeuticsIslet SciencesMergers & Acquisitions

Anaphore buys Chinese firm RuiYi for GPCR biologics platform


Privately-held US company Anaphore says it has acquired Shanghai, China-based RuiYi, bringing the company…

AnaphoreAsia-PacificBiotechnologyMergers & AcquisitionsRuiYi

NicOx takes option to buy UK ophthalmic company


French biotechnology firm NicOx (Euronext Paris: COX) has entered into an agreement to acquire 11.8%…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

AbbVie selected as name for Abbott research-based spin out


Confirming its previous announcements on plans to split the US health care major, Abbott Laboratories…

Abbott LaboratoriesAbbVieMergers & AcquisitionsPharmaceutical

Synergy Health buys only Swiss gamma and X-ray irradiation facility


UK-based Synergy Health (LSE: SYR), a provider of outsourced sterilization services to the medical device…

Leoni StuderMergers & AcquisitionsPharmaceuticalSynergy Health

Flamel Tech acquires US firm Eclat Pharma; reports loss


Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Grifols acquires 51% stake in Araclon Biotech


Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

751 to 775 of 915 results

Back to top